Aurobindo Pharma completes ₹800 crore buyback of equity shares
after close1 source ↓written by the desknot a recommendation
- ₹800 crore buyback programme
- through a tender
- ₹1,475 per share
- and closed
- 23 April 2026
- and closed
- 29 April 2026
Aurobindo Pharma has completed the extinguishment of 54,23,728 equity shares under its ₹800 crore buyback programme. The buyback was executed at ₹1,475 per share through a tender offer, which opened on 23 April 2026 and closed on 29 April 2026. This move may enhance shareholder value and improve earnings per share.
Not investment advice. For informational purposes only.